Clinical Trials
7 trialsNCT05451212 2025-11-10
Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis
Cabaletta Bio
Phase 1 Completed
NCT05881343 2023-05-31
COVID19&SURG
Istituto Ortopedico Rizzoli
Completed
NCT05493306 2022-08-12
Evaluation of Telerehabilitation Following Inpatient or Outpatient Rehabilitation Phase II
Pensionsversicherungsanstalt
Completed
NCT01960855 2021-08-24
A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic Therapy
AbbVie
Phase 2 Completed
NCT03072186 2021-04-26
ICG2
Ohio State University
Phase NA Completed
NCT00580788 2016-02-11
One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study
University of Pittsburgh
Phase EARLY_PHASE1 Completed
NCT00954746 2015-06-16
Longterm Observational Study in Subjects Treated With AA4500 in AUX-CC-854, 856, 857, 858 & 859
Endo Pharmaceuticals
Completed